Sharemaestro Newsreel

UBS Group Forecasts Strong Price Appreciation for Sight Sciences (NASDAQ:SGHT) Stock

AdaptHealth (AHCO) Stock Faces Deeper Doubts After Profit Reset

Canaccord raises Establishment Labs stock price target on strong US growth

Integer Holdings (ITGR) Stock Margins Improve As Debt Questions Persist

Pulsenmore (PLSM) investors back six proposals at 2026 AGM

Pulsenmore Ltd. (PLSM) announced that its shareholders approved all six proposals presented at the 2026 Annual General Meeting held on August 6, 2026. These proposals were previously detailed in the Notice of Annual General Meeting dated July 1, 2026, which was furnished to the …

IceCure Medical (ICCM) holders approve agenda after adjourned meeting

IceCure Medical Ltd. shareholders approved the agenda item during a Special General Meeting held on August 6, 2026. The meeting was initially adjourned due to a lack of quorum but reconvened later the same day once sufficient shareholder presence was achieved. This information was …

Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M

Hyperfine, Inc. reported a significant 44.8% increase in Q2 2026 revenue, reaching $3.9 million, with cash and cash equivalents growing to $43.5 million. The company also announced CE Mark and UKCA approvals and the European launch of its next-generation Swoop® portable MRI system, alongside …

Why Enovis (ENOV) Shares Are Sliding Today

Enovis Corporation's shares fell 12.8% after reporting second-quarter earnings, despite revenue and adjusted earnings surpassing Wall Street expectations. The decline was attributed to a weaker full-year earnings per share outlook and a significant contraction in the company's adjusted operating margin, which fell 6.7 percentage …

Artivion Reports Second Quarter 2026 Financial Results

Artivion, Inc. announced strong financial results for the second quarter of 2026, with revenue increasing 11% on a GAAP basis and 9% on a constant currency basis. The company reported adjusted EBITDA growth of 7% and highlighted key achievements including the acquisition of Endospan …

Medical equipment company to close St. Louis-area plant as it moves work to new $600M facility in NC

A global medical equipment company is planning to invest $600 million in a new manufacturing and distribution hub in North Carolina. This development will result in the closure of its existing St. Louis-area plant, with operations being consolidated into the new facility. The move …

UFP Technologies (UFPT) Stock Jumps As Record EPS Reshapes The Debate

BTIG raises Haemonetics stock price target to $96 on strong results

BTIG has increased its price target for Haemonetics Corp. (NYSE:HAE) to $96 from $84, maintaining a Buy rating after the company reported strong first-quarter revenues and adjusted earnings per share that surpassed consensus estimates. All segments performed well, with Interventional Technologies returning to growth …

iRhythm earnings up next: Narrowing losses in focus tonight

iRhythm Technologies Inc. is scheduled to report second-quarter earnings, with analysts expecting a narrower loss of 5 cents per share and revenue of $219.3 million, indicating substantial improvement from the previous quarter. Investors will be focused on the company's ability to maintain rapid growth …

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

electroCore, Inc. (ECOR) reported a Q2 loss of $0.33 per share, exceeding the Zacks Consensus Estimate of a $0.41 loss, and posted revenues of $9.45 million, surpassing estimates by 0.92%. The company's stock has gained 45.6% year-to-date, outperforming the S&P 500. Currently, electroCore holds …

MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph

This document is a statement of changes in beneficial ownership of securities for Director Johnston John Joseph at MaxCyte. These types of filings are routine disclosures required for company insiders. The specific details of the changes in ownership are contained within the document.

Neogen Corp (NASDAQ: NEOG) CEO notes son's indirect buy of 370 shares

Neogen Corp CEO Mikheal Nassif reported an indirect purchase of 370 shares of Common Stock at $11.81 per share on August 4, 2026. The shares are held by his son, bringing the reported indirect holdings to 1,074 shares, though Nassif disclaims beneficial ownership. This …

TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3

TD Cowen has reiterated its Buy rating on Pacific Biosciences of California (PACB.US) and maintained its target price at $3. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Artivion earnings on deck: Can FDA approval revive growth? By Investing.com

Artivion Inc. is set to report its second-quarter earnings, with investors focusing on whether its recent FDA premarket approval for the AMDS Hybrid Prosthesis can counteract slowing sales and revive growth. Despite a 46% drop in shares from their 52-week high and a sequential …

All eyes on Quidel earnings as estimates tumble, asset sale looms

Quidel Corporation is set to report its second-quarter earnings after market close on Thursday, August 6, 2026, with analysts anticipating a loss of 4 cents per share. Investor confidence has waned due to declining EPS estimates and uncertainty surrounding the potential $1.5 billion sale …

Standard BioTools Inc. (LAB) Stock Price, News, Quote & History

This article provides comprehensive financial information for Standard BioTools Inc. (LAB), including its current stock price, historical data, and analyst ratings. It details the company's overview, its segments in proteomics and genomics, key products like the SomaScan platform and CyTOF technology, and financial performance …

Standard BioTools Reports Second Quarter 2026 Financial Results

Standard BioTools Inc. announced its financial results for the second quarter of 2026, reporting $20.1 million in revenue and an 84% improvement in adjusted EBITDA year-over-year. The company is progressing with its merger with Treeline Biosciences, anticipated to close before year-end 2026, and has …

Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) reported a Q2 loss of $0.31 per share, exceeding the Zacks Consensus Estimate of a $0.34 loss, marking an 8.82% surprise. Despite this, the company's Q2 revenues of $254.56 million missed the consensus estimate by 0.1%, leading to an …

LivaNova PLC (LIVN) (Q2 2026) Earnings Call Highlights: Record Revenue and EPS, Raised Guidance ...

LivaNova PLC (LIVN) reported record revenue of $391 million and adjusted EPS of $1.26 for Q2 2026, driven by strong growth in both Cardiopulmonary and Epilepsy segments. The company raised its full-year 2026 revenue guidance to 8%-9% growth and adjusted EPS guidance to $4.30-$4.40, …

Delcath Systems Inc (DCTH) Beats Revenue Estimates with $29.1 Million in Q2 Earnings: GF Score 73/100, 66.7% Undervalued

Delcath Systems Inc (DCTH) reported Q2 2026 revenue of $29.1 million, surpassing analyst estimates, driven by strong HEPZATO KIT sales. Despite increased R&D expenses, the oncology company maintained stable net income and improved gross margins. Delcath is well-positioned for future growth with a robust …

Stryker Corp To Go Ex-Dividend On September 30th, 2026 With 0.88 USD Dividend Per Share

Stryker Corp (NYSE:SYK) is set to go ex-dividend on September 30th, 2026, with a dividend payment of $0.88 per share. This financial event is important for investors to note as it affects who receives the upcoming dividend.

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

Outset Medical, Inc. (OM) reported a Q2 loss of $0.8 per share, which was wider than the Zacks Consensus Estimate of a $0.63 loss. However, the company surpassed revenue estimates, posting $31.64 million for the quarter, exceeding the consensus by 9.84%. Despite the earnings …

Insulet Valuation Attractive Despite Growth Reset Risk, RBC Says

RBC views Insulet's valuation as attractive despite potential risks associated with its growth strategy and upcoming competition. The article briefly mentions Insulet's challenges in serving Type 2 diabetes patients. Full access to the MT Newswires article requires a premium subscription.

CONMED Corporation $CNMD Shares Sold by Edgestream Partners L.P.

Edgestream Partners L.P. significantly reduced its stake in CONMED Corporation (NYSE:CNMD) during the first quarter, selling 87.4% of its shares. Despite this, CONMED reported strong quarterly earnings, surpassing analyst expectations for both EPS and revenue, and maintained its fiscal 2026 EPS guidance. Analyst sentiment …

Lucid Diagnostics Inc (LUCD) News, Articles, Events & Latest Updates

This article provides a compilation of recent news and updates regarding Lucid Diagnostics Inc. (LUCD), including coverage policies for its EsoGuard test, upcoming investor conference participations, and quarterly earnings reports from related companies. It also mentions a price target reduction for LUCD despite expected …

FMR LLC (LIVN) discloses 5.8% LivaNova stake in Schedule 13G filing

FMR LLC has filed a Schedule 13G, disclosing a beneficial ownership of 5.8% in LivaNova PLC (LIVN) common stock, amounting to 3,210,395.27 shares as of June 30, 2026. Both FMR LLC and Abigail P. Johnson reported this stake, with FMR LLC holding sole voting …

LivaNova PLC Stock 12‑Month Price Target Raised to $88.78, Implies 4% Upside

LivaNova PLC (LIVN) has seen its average 12-month price target increased from $86.78 to $88.78 by 9 analysts, with individual forecasts ranging from $75 to $95. This new target suggests a potential upside of approximately 4% from its closing price on August 4. The …

Bioventus (BVS) Stock Jumps On Profit Strength As Growth Risks Remain

Bioventus (BVS) stock surged 13.7% following a strong Q2 earnings report, showcasing adjusted EBITDA of US$35 million on US$153.2 million revenue and healthy cash generation. While the company's profitability and cash flow are positive, concerns remain regarding its reliance on a narrow product set, …

IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment

IceCure Medical has announced that Adventist Health Glendale will be the first U.S. clinical site to enroll patients in its post-marketing "ChoICE" study for ProSense® cryoablation treatment of low-risk breast cancer. The study aims to gather real-world data on up to 400 patients across …

Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $104.9, Implies 7% Upside

Zimmer Biomet Holdings, Inc.'s average price target has been increased to $104.9, up from $104.26, according to 20 analysts. This updated target suggests a potential 7% upside based on the Aug. 5 closing price. The consensus rating among 29 analysts remains a "Buy," with …

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

PacBio reported an adjusted loss per share of 14 cents for Q2 2026, meeting estimates, but revenues of $39 million missed expectations and were down 2% year over year. The company reduced its 2026 revenue guidance to $155-$165 million due to weaker instrument sales, …

UFP TECHNOLOGIES INC SEC Filing (Aug 6, 2026)

UFP Technologies Inc. (UFPT) filed a Form 144 with the SEC on August 6, 2026, indicating a proposed sale of 1100 shares of common stock by an unnamed individual. The shares, acquired via a stock award from the issuer on March 3, 2025, have …